Golden State Equity Partners - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
Golden State Equity Partners ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$308,000
+14.5%
41,8500.0%0.16%
+14.0%
Q4 2021$269,000
+54.6%
41,850
+39.7%
0.14%
+91.5%
Q3 2021$174,000
-23.7%
29,953
+35.5%
0.07%
-19.3%
Q2 2021$228,000
+101.8%
22,103
+106.6%
0.09%
+37.5%
Q1 2021$113,00010,6970.06%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders